These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 9687536)
1. Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. Li S; Kurts C; Köntgen F; Holdsworth SR; Tipping PG J Exp Med; 1998 Aug; 188(3):597-602. PubMed ID: 9687536 [TBL] [Abstract][Full Text] [Related]
2. IFN-gamma production by intrinsic renal cells and bone marrow-derived cells is required for full expression of crescentic glomerulonephritis in mice. Timoshanko JR; Holdsworth SR; Kitching AR; Tipping PG J Immunol; 2002 Apr; 168(8):4135-41. PubMed ID: 11937574 [TBL] [Abstract][Full Text] [Related]
3. MHC class I pathway is not required for the development of crescentic glomerulonephritis in mice. Li S; Holdsworth SR; Tipping PG Clin Exp Immunol; 2000 Dec; 122(3):453-8. PubMed ID: 11122254 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-12 from intrinsic cells is an effector of renal injury in crescentic glomerulonephritis. Timoshanko JR; Kitching AR; Holdsworth SR; Tipping PG J Am Soc Nephrol; 2001 Mar; 12(3):464-471. PubMed ID: 11181794 [TBL] [Abstract][Full Text] [Related]
5. Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. Timoshanko JR; Sedgwick JD; Holdsworth SR; Tipping PG J Am Soc Nephrol; 2003 Jul; 14(7):1785-93. PubMed ID: 12819238 [TBL] [Abstract][Full Text] [Related]